News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2023-12-19 4:40:40 am Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday InvestorPlace
2023-12-18 1:1:0 pm INmune Bio Provides Update Regarding Global Alzheimer’s Phase II Clinical Trial and Clinical Hold Issued by the United States FDA GlobeNewswire
2023-11-29 5:0:0 am INmune Bio Inc. Demonstrates that INB03 Enhances the Uptake of Trastuzumab Deruxtecan in HER2+ Breast Cancer with MUC4 Expression in Poster Presented at San Antonio Breast Cancer Symposium GlobeNewswire
2023-11-27 5:0:0 am INmune Bio Receives EMA’s Authorization in France and Spain for Phase II Clinical Trial of XPro™ for Early Alzheimer’s Disease GlobeNewswire
2023-11-17 5:15:10 am Quest For Alzheimer's Cure: Big Biotech Breakthroughs, But The Race Is Just Beginning Investor's Business Daily
2023-11-15 6:0:0 am INmune Bio Inc. Announces Expansion of Phase II Clinical Trial for Alzheimer’s Disease in Europe GlobeNewswire
2023-11-02 7:11:10 am INmune Bio, Inc. (NASDAQ:INMB) Q3 2023 Earnings Call Transcript Insider Monkey
2023-11-02 6:54:43 am Q3 2023 INmune Bio Inc Earnings Call Thomson Reuters StreetEvents
2023-11-01 3:44:14 pm INmune Bio Inc (INMB) Reports Q3 2023 Financial Results GuruFocus.com
   

Please consider a small donation if you think this website provides you with relevant information